Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid


The healthcare sector isn't the first place income investors turn to find high dividend yields. Of the 11 S 500 sectors ranked based on average dividend yield, healthcare comes in eighth.

Plenty of healthcare stocks, though, pay juicy dividends. Some are good picks, but others aren't. Here's one ultra-high-yield healthcare stock to buy hand over fist -- and one to avoid.

Some investors might think (NYSE: PFE) is a healthcare stock to avoid rather than buy hand over fist. That view is understandable if you only look at the drugmaker's recent history. Pfizer's share price has plunged over 50% from the peak set in late 2021. Although the stock has risen this year, it's barely in positive territory with a meager gain that lags well behind the S 500's strong return.

Continue reading


Source Fool.com

Pfizer Inc. Stock

€21.12
-0.570%
The price for the Pfizer Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.120 (-0.570%).
With 20 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 40 € there is a hugely positive potential of 89.44% for Pfizer Inc. compared to the current price of 21.12 €.
Like: 0
PFE
Share

Comments